Provectus Pharmaceuticals Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Provectus Pharmaceuticals Inc.

PVCT 0.0630

-1.6%

Nov 28 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: boomertree2	5/17/2012 10:43:28 AM
	2 Recommendations of 13111

FDA Reviews More Drugs Faster Than Europe Or Canada. The AP (5/17, Perrone) reports in a story appearing on over 230 news sites on a study published in the New England Journal of Medicine, based on "analysis by researchers at Yale and the Mayo Clinic" finding that "the US approved more new medicines in less time than Europe and Canada in the last decade, challenging long-standing criticisms that the Food and Drug Administration lags behind its peers in clearing important new drugs." Overall, the study found that "between 2001 and 2010, the FDA's typical review of a new drug was about 15 percent faster than those by the European Medicines Agency and Health Canada." MedPage Today (5/17) reports, "The speed at which the FDA approves medications has significantly improved since the passage of the Prescription Drug User Fee Act (PDUFA) in 1992."

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next